CERTAIN IDENTIFIED INFORMATION MARKED [***] HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.Asset Purchase Agreement • March 10th, 2023 • Sol-Gel Technologies Ltd. • Pharmaceutical preparations • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), is made and entered into as of January 23, 2023 (the “Agreement Date”), by and between Sol-Gel Technologies Ltd., a company organized under the laws of the State of Israel (“Purchaser”), and PellePharm, Inc., a Delaware corporation (“Seller”).
